[OR-39] Validity and safety preclinical in vivo study of gene therapy for hypophosphatasia using ARU-2801 (AAV8 vector expressing TNALP-D10)
Abstract password authentication.
The password was sent to all registrants in email. You can also check it in abstracts and a live streamig site.